About this trial

The aim of this study is to evaluate the effects of the steep Trendelenburg position in robotic prostatectomy cases, where anesthesia depth is monitored using BIS and cerebral perfusion is tracked with NIRS, and to determine the incidence of neurocognitive dysfunction using the MoCA test in the postoperative period.

Steep Trendelenburg position and CO₂ pneumoperitoneum during robotic radical prostatectomy lead to significant changes in intracranial pressure and cerebral oxygenation, which may contribute to postoperative neurocognitive dysfunction (POCD). Monitoring anesthesia depth with Bispectral Index (BIS) and cerebral perfusion with Near-Infrared Spectroscopy (NIRS) may help detect early neurocognitive changes, and MoCA test assessments will reveal a measurable decline in cognitive function postoperatively.

Eligibility criteria

Qualifiers

Age ≥ 65 years

ASA II-III risk score

Patients scheduled for robotic radical prostatectomy

Patients who voluntarily agree to participate

Disqualifiers

Age < 65 years

History of neurological or psychiatric disorders

Inability to undergo robotic surgery

Conversion to open prostatectomy during surgery

Trial design

Treatments tested in this trial

  • Montreal Cognitive Assessment

Treatment groups

No treatment groups listed

Locations

1
Ankara City Hospital Bilkent Ankara Turkey (Türkiye)

Sponsors and collaborators

Ankara City Hospital Bilkent

Lead sponsor